Positive crosstalk between EGFR and the TF-PAR2 pathway mediates resistance to cisplatin and poor survival in cervical cancer

Cisplatin-based chemoradiation is the standard treatment for cervical cancer, but chemosensitizing strategies are needed to improve patient survival. EGFR (Epidermal Growth Factor Receptor) is an oncogene overexpressed in cervical cancer that is involved in chemoresistance. Recent studies showed tha...

全面介紹

Na minha lista:
書目詳細資料
發表在:Oncotarget
Main Authors: Hugo de Almeida, Vitor, Guimarães, Isabella dos Santos, Almendra, Lucas R., Rondon, Araci M.R., Tilli, Tatiana M., de Melo, Andréia C., Sternberg, Cinthya, Monteiro, Robson Q.
格式: Artigo
語言:Inglês
出版: Impact Journals LLC 2018
主題:
Research Paper
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC6078136/
https://ncbi.nlm.nih.gov/pubmed/30093972
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.25748
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍